Also, exome sequencing of a large ALS patient cohort identified several mutations in the J-domain protein DNAJC7 that led to reduced protein levels in patient-derived fibroblasts (Farhan et al., 2019). The gene discussed is DNAJC7; the disease is amyotrophic lateral sclerosis.